Trials / Completed
CompletedNCT03896243
Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Investigators would like to see the amh values after uterine artery ligation
Detailed description
Group/cohort: Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC) Control Group: Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Uterine artery ligation (UAL) | Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC) |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-01-01
- Completion
- 2019-02-01
- First posted
- 2019-03-29
- Last updated
- 2019-03-29
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03896243. Inclusion in this directory is not an endorsement.